These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 17077244)

  • 1. Improved survival with an intact DNA mismatch repair system in endometrial cancer.
    Cohn DE; Frankel WL; Resnick KE; Zanagnolo VL; Copeland LJ; Hampel H; Kelbick N; Morrison CD; Fowler JM
    Obstet Gynecol; 2006 Nov; 108(5):1208-15. PubMed ID: 17077244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between patient weight and defects in DNA mismatch repair: is this the link between an increased risk of previous cancer in thinner women with endometrial cancer?
    Cohn DE; Pavelka JC; Frankel WL; Morrison CD; Hampel H; Copeland LJ; Fowler JM
    Int J Gynecol Cancer; 2008; 18(1):136-40. PubMed ID: 17466051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.
    Buchanan DD; Tan YY; Walsh MD; Clendenning M; Metcalf AM; Ferguson K; Arnold ST; Thompson BA; Lose FA; Parsons MT; Walters RJ; Pearson SA; Cummings M; Oehler MK; Blomfield PB; Quinn MA; Kirk JA; Stewart CJ; Obermair A; Young JP; Webb PM; Spurdle AB
    J Clin Oncol; 2014 Jan; 32(2):90-100. PubMed ID: 24323032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated levels of the mismatch repair protein PMS2 are associated with prostate cancer.
    Norris AM; Woodruff RD; D'Agostino RB; Clodfelter JE; Scarpinato KD
    Prostate; 2007 Feb; 67(2):214-25. PubMed ID: 17044039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Women 50 years or younger with endometrial cancer: the argument for universal mismatch repair screening and potential for targeted therapeutics.
    Ring KL; Connor EV; Atkins KA; Ricketts W; Kashlan B; Modesitt SC
    Int J Gynecol Cancer; 2013 Jun; 23(5):853-60. PubMed ID: 23552806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic significance of DNA mismatch repair protein defects and endometrial cancer in women 40years of age and younger.
    Shih KK; Garg K; Levine DA; Kauff ND; Abu-Rustum NR; Soslow RA; Barakat RR
    Gynecol Oncol; 2011 Oct; 123(1):88-94. PubMed ID: 21742371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of MMR in endometrial adenocarcinoma in women under 50 years old].
    Wu HX; Song JC; Shi YQ; Liu YX
    Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):733-6. PubMed ID: 23302332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative diagnosis of Lynch syndrome with DNA mismatch repair immunohistochemistry on a diagnostic biopsy.
    Warrier SK; Trainer AH; Lynch AC; Mitchell C; Hiscock R; Sawyer S; Boussioutas A; Heriot AG
    Dis Colon Rectum; 2011 Dec; 54(12):1480-7. PubMed ID: 22067175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent advances and future development on Lynch syndrome-associated endometrial cancer].
    Ning Y; Wang Y; Wang YY; Zheng WX
    Zhonghua Bing Li Xue Za Zhi; 2013 Aug; 42(8):505-8. PubMed ID: 24246913
    [No Abstract]   [Full Text] [Related]  

  • 10. DNA mismatch repair defects and microsatellite instability status in periocular sebaceous carcinoma.
    Rajan Kd A; Burris C; Iliff N; Grant M; Eshleman JR; Eberhart CG
    Am J Ophthalmol; 2014 Mar; 157(3):640-7.e1-2. PubMed ID: 24321472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interobserver variability in the evaluation of mismatch repair protein immunostaining.
    Klarskov L; Ladelund S; Holck S; Roenlund K; Lindebjerg J; Elebro J; Halvarsson B; von Salomé J; Bernstein I; Nilbert M
    Hum Pathol; 2010 Oct; 41(10):1387-96. PubMed ID: 20573374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas.
    Felsberg J; Thon N; Eigenbrod S; Hentschel B; Sabel MC; Westphal M; Schackert G; Kreth FW; Pietsch T; Löffler M; Weller M; Reifenberger G; Tonn JC;
    Int J Cancer; 2011 Aug; 129(3):659-70. PubMed ID: 21425258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: report from the constitutional mismatch repair deficiency consortium.
    Bakry D; Aronson M; Durno C; Rimawi H; Farah R; Alharbi QK; Alharbi M; Shamvil A; Ben-Shachar S; Mistry M; Constantini S; Dvir R; Qaddoumi I; Gallinger S; Lerner-Ellis J; Pollett A; Stephens D; Kelies S; Chao E; Malkin D; Bouffet E; Hawkins C; Tabori U
    Eur J Cancer; 2014 Mar; 50(5):987-96. PubMed ID: 24440087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
    Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA
    Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue identity testing of cancer by short tandem repeat polymorphism: pitfalls of interpretation in the presence of microsatellite instability.
    Much M; Buza N; Hui P
    Hum Pathol; 2014 Mar; 45(3):549-55. PubMed ID: 24444463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhabdomyosarcoma in patients with constitutional mismatch-repair-deficiency syndrome.
    Kratz CP; Holter S; Etzler J; Lauten M; Pollett A; Niemeyer CM; Gallinger S; Wimmer K
    J Med Genet; 2009 Jun; 46(6):418-20. PubMed ID: 19293170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of expression of DNA mismatch repair proteins is rare in pancreatic and small intestinal neuroendocrine tumors.
    Arnason T; Sapp HL; Rayson D; Barnes PJ; Drewniak M; Nassar BA; Huang WY
    Arch Pathol Lab Med; 2011 Dec; 135(12):1539-44. PubMed ID: 22129180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas.
    McConechy MK; Talhouk A; Li-Chang HH; Leung S; Huntsman DG; Gilks CB; McAlpine JN
    Gynecol Oncol; 2015 May; 137(2):306-10. PubMed ID: 25636458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma.
    Hall G; Clarkson A; Shi A; Langford E; Leung H; Eckstein RP; Gill AJ
    Pathology; 2010; 42(5):409-13. PubMed ID: 20632815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA mismatch repair-related protein loss as a prognostic factor in endometrial cancers.
    Kato M; Takano M; Miyamoto M; Sasaki N; Goto T; Tsuda H; Furuya K
    J Gynecol Oncol; 2015 Jan; 26(1):40-5. PubMed ID: 25310854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.